IP Library › Granted Patent US 12,065,463
Granted Patent B2
US 12,065,463 · App. 17/971,865 · Granted Aug 20, 2024

Compositions and methods for treating CNS disorders

Inventors: Gabriel Martinez Botella (Wayland, MA); Francesco G. Salituro (Marlborough, MA); Albert Jean Robichaud (Boston, MA); Boyd L. Harrison (Princeton Junction, NJ)
Assignee: Sage Therapeutics, Inc.
C07J43/003A61K31/575A61K31/58A61K45/06C07J9/00C07J1/0011C07J1/0022C07J3/005C07J5/0053C07J7/002C07J7/007C07J7/008C07J11/00C07J13/007C07J21/00C07J31/006C07J41/0066C07J51/00C07J71/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,065,463
App. No.
17/971,865
Granted
Aug 20, 2024
Kind
B2
Abstract

Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof, wherein , A, R 1 , R 2 , R 3a , R 4a , R 4b , R 5 , R 7a , and R 7b are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.

Claims (3)

1. A compound of the formula

2. A pharmaceutical composition comprising a compound of the formula

and a pharmaceutically acceptable excipient.

Assignments (2)
CHANGE OF NAME Recorded Apr 23, 2026
From: SAGE THERAPEUTICS, INC.
To: SAGE THERAPEUTICS, LLC
Reel/Frame 075472/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2023
From: MARTINEZ BOTELLA, GABRIEL; SALITURO, FRANCESCO G.; ROBICHAUD, ALBERT JEAN; HARRISON, BOYD L.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 062478/0302 →